AngioDynamics launches platinum biliary stent in US:
This article was originally published in Clinica
E-Z-EM's wholly owned subsidiary AngioDynamics is to launch its VISTAFLEX platinum biliary stent in the US this month. The Queensbury, New York-based company, which presented the product at the Radiological Society of North America meeting in Chicago last week, says the stent is a unique combination of visibility under fluoroscopy and flexibility. It is also the only available stent which is compatible with magnetic resonance angiography, AngioDynamics says.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.